SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending due to high volume and price volatility, sparking discussions around potential insider selling following a lock-up period expiration. The community is debating whether the dip represents a buying opportunity or a sign of further declines, with some citing oversold conditions and potential for a rebound. Others express concern over the company's fundamentals and the impact of potential dilution.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

Recursion Pharmaceuticals Inc

RXRX is trending as traders discuss the potential for a short squeeze, pointing to its high short interest and unusual options activity. Some believe the company's AI-driven drug discovery platform and partnerships with companies like NVDA could be a catalyst. Others remain cautious, noting concerns around cash burn and insider selling.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recently closed $75 million investment focused on AI connectivity, fueling speculation about the institutional investor behind the deal and potential strategic implications for the company. Community discussions revolve around POET's role in addressing bottlenecks in AI data centers and the potential for partnerships or M&A activity in the AI hardware space. Bullish sentiment is high, with many anticipating significant upside potential and comparing it to other high-growth tech sectors.

American Rebel Holdings, Inc. engages in the design and marketing of branded safes, and personal security and self-defense products. It also designs and manufactures branded apparel and accessories. The company was founded on December 15, 2014 and is headquartered in Brentwood, TN.

American Rebel Holdings Inc

American Rebel Holdings ($AREB) is trending amidst discussions around trading halts, potential breakout points, and the stock's history of multi-day runs. Community members are actively debating its short-squeeze potential and consolidation patterns, with some pointing to a possible 'squirt' to higher levels. Additionally, the buzz around recent biotech releases is contributing to the heightened interest in $AREB.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amid renewed buyout speculation and anticipation for upcoming trial catalysts, especially following competitor acquisitions in the obesity and NASH space. Community members highlight VKTX's strong pipeline, potential for best-in-class efficacy, and a growing sense that the market is undervaluing the stock relative to recent deals. A possible short squeeze due to high short interest also fuels interest.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending as investors flock to the safe-haven asset amid concerns about the government shutdown and broader economic uncertainty. Community chatter highlights gold's potential to reach new highs, with some viewing it as a hedge against potential market downturns or a declining dollar. Discussions also include the relationship between gold, equities, and crypto.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is trending due to renewed optimism surrounding gene editing and recent insider buying, sparking community discussion about its long-term potential. Bullish sentiment is driven by advancements in CRISPR-Cas9 technology and excitement around potential applications for curing diseases. The community is closely watching for further developments and data releases that could serve as catalysts for significant price movement.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending as investors discuss its potential for a short squeeze and await further data, particularly regarding CAN-3110. Community talking points include speculation about upcoming news, potential partnerships, and the company's valuation relative to its pipeline. Some traders express bullish sentiment, while others remain cautious, citing past performance and concerns about management.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending as it approaches all-time highs, fueled by recent FDA clearance of its AI-powered cardiac imaging platform and a large NIH contract. The community is discussing its potential to break the $100 mark, with some pointing to a high short interest as a catalyst for a potential squeeze, while others are wary of its valuation.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

AlphaTON Capital (ATON) is trending due to its focus on tokenizing its mesothelioma treatment program and merging blockchain technology with cancer therapeutics, sparking debate about the company's direction. Community discussions revolve around potential pump-and-dump schemes and the stock's volatility, while some see opportunity in its unique approach to decentralized science. ATON's movements are also being compared to other volatile stocks like XBIO, NXL and ECDA, with traders actively seeking the next high-potential runner.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Bowman Consulting Group (BWMN) Outperforming Other Business Services Stocks This Year?

Here is how Bowman Consulting (BWMN) and CompoSecure, Inc. (CMPO) have performed compared to their sector so far this year.

What Makes Bowman Consulting (BWMN) a Good Fit for 'Trend Investing'

If you are looking for stocks that are well positioned to maintain their recent uptrend, Bowman Consulting (BWMN) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Do Options Traders Know Something About Bowman Consulting Stock We Don't?

Investors need to pay close attention to BWMN stock based on the movements in the options market lately.

Is CompoSecure (CMPO) Stock Outpacing Its Business Services Peers This Year?

Here is how CompoSecure, Inc. (CMPO) and Bowman Consulting (BWMN) have performed compared to their sector so far this year.

Bowman Consulting (BWMN) is on the Move, Here's Why the Trend Could be Sustainable 

Bowman Consulting (BWMN) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Cintas Gains From Business Strength Amid Persisting Headwinds

CTAS posts strong gains with segment growth, acquisitions and higher shareholder returns, but rising costs remain a challenge.

Is Bowman Consulting Group (BWMN) Stock Outpacing Its Business Services Peers This Year?

Here is how Bowman Consulting (BWMN) and Concentrix Corporation (CNXC) have performed compared to their sector so far this year.

Recent Price Trend in Bowman Consulting (BWMN) is Your Friend, Here's Why

Bowman Consulting (BWMN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Bowman Consulting (BWMN) Beats Q2 Earnings and Revenue Estimates

Bowman Consulting (BWMN) delivered earnings and revenue surprises of +266.67% and +2.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

UL Solutions Inc. (ULS) Q2 Earnings and Revenues Surpass Estimates

UL Solutions Inc. (ULS) delivered earnings and revenue surprises of +10.64% and +0.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Bowman Consulting Group Ltd. operates as a professional services firm delivering innovative engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, survey, land procurement and technical services. The company was founded by Gary P. Bowman in 1995 and is headquartered in Reston, VA.

Bowman Consulting Group Ltd

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$42.29
Prev Close	$41.59
Open	$41.95
Dividend Yield	0.00%
50-Day Moving Average	$40.12
Beta	0.88
Avg. Volume	124,973.43
PE Ratio	67.12

52-Week High	$44.25
52-Week Low	$17.90
Market Capitalization	$717.46M
EPS (Annual)	$0.1738
Price to Book	2.87
Revenue Per Employee	$193,892.73
Enterprise Value/EBITDA	N/A

BWMN
Bowman Consulting Group Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BWMN News

BWMN Bowman Consulting Group Ltd